MaxCyte Inc Stock
Your prediction
MaxCyte Inc Stock
MaxCyte Inc dominated the market today, gaining €0.030 (3.410%).
Our community identified positive and negative aspects for MaxCyte Inc stock for the coming years. 1 users see the criterium "Management" as a plus for the MaxCyte Inc stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of MaxCyte Inc in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of MaxCyte Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| MaxCyte Inc | 3.410% | - | - | - | - | - | - |
| Larimar Therapeutics Inc. | 5.060% | -5.682% | 25.758% | 24.812% | 0.000% | 19.424% | -61.618% |
| Northwest Biotherapeutics Inc. | -1.330% | 0.000% | 2.069% | -35.088% | -28.155% | -68.511% | -86.038% |
| Achieve Life Sciences Inc. | 1.890% | 0.935% | 0.000% | 135.808% | 45.946% | 5.882% | -10.744% |